US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Johnson & Johnson

155.91

+0.56000.36%

Post-market: 155.910.00000.00%19:59 EDT

Volume:5.25M

Turnover:818.88M

Market Cap:375.13B

PE:17.35

High:157.02

Open:155.45

Low:154.29

Close:155.35

Loading ...

Overview Company News Filings

Pharma Stock Roundup: RHHBY Obesity Drug Rights Buyout, NVO Pipeline Update

Press Release: AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update

Johnson & Johnson (NYSE:JNJ) Reports Positive Phase 2b Trial Results For Ulcerative Colitis Treatment

Simply Wall St.

PTGX Up as J&J-Partnered Drug Meets Goal in Ulcerative Colitis Study

Protagonist Therapeutics Soars as Icotrokinra Drives Breakthrough Success

TuHURA Biosciences, Inc Appoints Craig L. Tendler M.D., Former Vice President, Oncology Clinical Development, Diagnostics, and Global Medical Affairs, Johnson & Johnson Innovative Medicine Research & Development, to its Board of Directors

ACCESS Newswire

Breakfast News: The Rout Continues

Genmab sinks as J&J opts not to develop Darzalex successor; stock upgraded

BUZZ-Genmab falls after J&J Hexabody opt-out

Analysts’ Opinions Are Mixed on These Healthcare Stocks: BridgeBio Pharma (BBIO), Johnson & Johnson (JNJ) and Lexicon Pharmaceuticals (LXRX)

Are High-Yield Dividend Stocks Best for Income-Focused Investors?

How Exxon Mobil, Johnson & Johnson, And Cogent Communications Can Put Cash In Your Pocket

Johnson & Johnson's Ulcerative Colitis Drug Hits Key Trial Goals, Stock Rises

Top Midday Gainers

MT Newswires Live

Eli Lilly CEO David Ricks' pay rose to almost $30 million in 2024

BRIEF-Genmab Says Johnson & Johnson Will Not Exercise Option For Hexabody-Cd38 License

Expectations for J&J Genmab opt-in lowered ahead of news, says Morgan Stanley

Genmab’s HexaBody-CD38 Development Halted After J&J Decision

BRIEF-J&J's oral drug to treat inflammation-causing condition in colon meets main goal in mid-stage study

Zacks Investment Ideas feature highlights: Coca-Cola, Philip Morris and Johnson & Johnson

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/JNJ/news?page=20"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"JNJ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JNJ\",,,,,undefined,":{"symbol":"JNJ","market":"US","secType":"STK","nameCN":"Johnson & Johnson","latestPrice":155.91,"timestamp":1745956800000,"preClose":155.35,"halted":0,"volume":5246431,"hourTrading":{"tag":"盘后","latestPrice":155.91,"preClose":155.91,"latestTime":"19:59 EDT","volume":309107,"amount":48192975.8161,"timestamp":1745971169906},"delay":0,"floatShares":2402378994,"shares":2406073279,"eps":8.984973,"marketStatus":"Closed","change":0.56,"latestTime":"04-29 16:00:00 EDT","open":155.45,"high":157.02,"low":154.29,"amount":818875856.70026,"amplitude":0.017573,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":8.984973,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746000000000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":-797371200000,"exchange":"NYSE","adjPreClose":155.35,"dividendRate":0.031813,"preHourTrading":{"tag":"盘前","latestPrice":155.4,"preClose":155.35,"latestTime":"09:29 EDT","volume":3274,"amount":509707.45160000003,"timestamp":1745933397624},"postHourTrading":{"tag":"盘后","latestPrice":155.91,"preClose":155.91,"latestTime":"19:59 EDT","volume":309107,"amount":48192975.8161,"timestamp":1745971169906},"volumeRatio":0.672528,"impliedVol":0.2268,"impliedVolPercentile":0.828},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JNJ\",,,,,undefined,":{"symbol":"JNJ","floatShares":2402378994,"roa":"7.74%","roe":"29.45%","lyrEps":5.84306,"volumeRatio":0.672528,"shares":2406073279,"dividePrice":4.96,"high":157.02,"amplitude":0.017573,"preClose":155.35,"low":154.29,"week52Low":140.68,"pbRate":"4.80","psRate":"4.20","week52High":169.99,"institutionHeld":0.6213,"latestPrice":155.91,"eps":8.984973,"divideRate":0.031813,"volume":5246431,"delay":0,"ttmEps":8.984973,"open":155.45,"prevYearClose":144.62,"prevWeekClose":154.58,"prevMonthClose":165.84,"prevQuarterClose":165.84,"fiveDayClose":157.75,"twentyDayClose":165.84,"sixtyDayClose":152.15},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"JNJ\",pageSize:20,pageCount:20,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2519863822","title":"Pharma Stock Roundup: RHHBY Obesity Drug Rights Buyout, NVO Pipeline Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2519863822","media":"Zacks","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519863822?lang=en_us&edition=fundamental","pubTime":"2025-03-14 01:05","pubTimestamp":1741885500,"startTime":"0","endTime":"0","summary":"This week, Novo Nordisk NVO announced disappointing data from a phase III study on a novel obesity candidate, CagriSema. Roche RHHBY announced a license and collaboration deal with Denmark’s Zealand Pharma to co-develop its lead obesity candidate petrelintide. Pfizer PFE and partner Arvinas ARVN announced mixed phase III data for breast cancer therapy, vepdegestrant. J&J JNJ and partner Protagonist Therapeutics’ investigational targeted oral peptide, icotrokinra met the primary endpoint of clinical response in ulcerative colitis study.Here's a recap of the week’s most important stories.NVO's Novel Obesity Treatment Disappoints in Phase III Study. Novo Nordisk’sphase III REDEFINE 2 study evaluating its next-gen subcutaneous obesity candidate, CagriSema, met its primary endpoint. CagriSema is a fixed-dose combination of a long-acting amylin analog, cagrilintide  and semaglutide .In the study, 61.9% of patients were given the highest dose of the drug.For the deal, Roche will make an upfro","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pharma-stock-roundup-rhhby-obesity-170500925.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1718418525.SGD","LU2129689605.HKD","03165","LU1894683264.USD","LU2602419157.SGD","BK4581","LU0912757837.SGD","LU1430594728.SGD","LU0225284248.USD","SG9999001176.USD","JNJ","LU0345769631.USD","IE00BGHQF631.EUR","MBC","NVO","LU0795875086.SGD","RHHBY","BK4559","LU0054578231.USD","ITT","LU2505996509.AUD","ZLDPF","LU0345770993.USD","LU0466842654.USD","SG9999011175.SGD","IE00B42XCP33.USD","IE00BLSP4239.USD","LU1093756168.USD","PFE","LU1066051811.HKD","LU0345769128.USD","LU1732799900.SGD","IE00B4R5TH58.HKD","LU1032955483.USD","LU0058720904.USD","LU1261432733.SGD","LU2089984988.USD","LU1244550221.USD","LU0053671581.USD","BK4007","LU0234570918.USD","LU2112291526.USD","BK4599","LU1032466523.USD","SG9999003800.SGD","LU2430703095.HKD","SG9999002232.USD","ARVN","IE00BDGV0183.EUR","IE00B19Z3581.USD"],"gpt_icon":1},{"id":"2519887682","title":"Press Release: AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2519887682","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519887682?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:00","pubTimestamp":1741863600,"startTime":"0","endTime":"0","summary":"-- Landmark exclusive option and license deal with Takeda for ACI-24.060. with $100 million upfront and additional potential milestones of up to. about $2.1 billion plus royalties on sales upon commercialization. -- ACI-24.060 ABATE Phase 1b/2 trial showed encouraging interim safety and. tolerability data in Down syndrome  cohort; further interim results. in Alzheimer's disease  and DS expected in 2025. -- Enrollment progress in JNJ-2056  ReTain Phase 2b trial in. preclinical AD patients triggered second milestone payment of CHF 24.6. -- ACI-7104.056 VacSYn Phase 2 trial demonstrated positive interim safety. and immunogenicity results in Parkinson's disease ; further interim. \"The ability to innovate is key to our future success. Driven by our two drug discovery platforms, in 2024, we advanced multiple early-stage asse","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0098860793.USD","LU0345769128.USD","BK4592","IE0009355771.USD","LU1244550577.SGD","BK4604","ACI","ACIU","03160","R","PD","BK4532","BK4581","IE00BSNM7G36.USD","LU0234570918.USD","LU0203345920.USD","CBD","SG9999002224.SGD","IE00B42XCP33.USD","PET","IE00B2B36J28.USD","BK4555","LU0114720955.EUR","LU2089984988.USD","JNJ","LU1032466523.USD","LU0234572021.USD","IE00B4R5TH58.HKD","AC","IE000M9KFDE8.USD","PSP","LU1059921491.USD","LU0912757837.SGD","LU2430703095.HKD","LU1778281490.HKD","LU1506573853.SGD","BK4007","LU0320765646.SGD","AAIC","LU1221951129.SGD","LU0640476718.USD","TM","LU0792757196.USD","IE00BVYPNV92.GBP","LU2505996509.AUD","IE00BDGV0183.EUR","LU1169589451.USD","ARIA","LU1244550494.USD","LU1162221912.USD"],"gpt_icon":0},{"id":"2518751778","title":"Johnson & Johnson (NYSE:JNJ) Reports Positive Phase 2b Trial Results For Ulcerative Colitis Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2518751778","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518751778?lang=en_us&edition=fundamental","pubTime":"2025-03-12 01:36","pubTimestamp":1741714590,"startTime":"0","endTime":"0","summary":"Johnson & Johnson recently experienced a 12% price increase over the last quarter, largely driven by significant announcements regarding its clinical trials, particularly the ANTHEM-UC study, which showcased promising results in ulcerative colitis treatment. These positive results provided a boost to investor confidence amid overall market volatility, triggered by economic concerns and trade issues, including tariffs announced by the Trump administration. The broader market faced a decline of approximately 4% during the same period, with tensions contributing to uncertainty. Despite a slight dip in net income for the fourth quarter of 2024, JNJ's continued commitment to product innovation, evidenced by multiple successful trials such as ICONIC-LEAD for psoriasis, has maintained its appeal. Additionally, the company's consistent dividend payouts of $1.24 per share demonstrate resilience, offering investors a sense of stability against the backdrop of broader market fluctuations.This art","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/johnson-johnson-nyse-jnj-reports-173630504.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B4R5TH58.HKD","LU0889566641.SGD","IE00BJT1NW94.SGD","LU2133065610.SGD","BK4504","IE00B2B36J28.USD","LU0320765646.SGD","LU1032955483.USD","LU1244550221.USD","LU0234572021.USD","BK4568","SG9999002232.USD","LU1221951046.USD","LU1023059063.AUD","BK4592","LU0466842654.USD","LU1061106388.HKD","BK4585","BK4559","LU0234570918.USD","NYSE","LU2430703178.SGD","LU2468319806.SGD","JNJ","IE00B3PB1722.GBP","IE00B1BXHZ80.USD","LU1221951129.SGD","IE00B42XCP33.USD","LU0122379950.USD","LU0098860793.USD","IE0009355771.USD","LU1074936037.SGD","LU2089984988.USD","LU1935042991.SGD","LU0345769128.USD","LU2430703251.USD","IE00BGHQF631.EUR","LU0345770993.USD","SG9999002224.SGD","LU0058720904.USD","LU0795875169.SGD","LU2112291526.USD","IE00B19Z3581.USD","LU0345770308.USD","LU1718418525.SGD","LU2505996509.AUD","LU0640476718.USD","LU1066051498.USD","LU0203345920.USD","BK4581"],"gpt_icon":0},{"id":"2518727781","title":"PTGX Up as J&J-Partnered Drug Meets Goal in Ulcerative Colitis Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2518727781","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518727781?lang=en_us&edition=fundamental","pubTime":"2025-03-12 00:15","pubTimestamp":1741709700,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics, Inc. PTGX announced positive top-line data from the phase IIb ANTHEM-UC study, which evaluated icotrokinra , an investigational targeted oral peptide that selectively blocks the IL-23 receptor, for treating adults with moderately to severely active ulcerative colitis , a chronic disease of the large intestine.The ANTHEM-UC study, conducted by Protagonist's partner, Johnson & Johnson JNJ, met its primary endpoint of clinical response in all icotrokinra dose groups.Treatment with icotrokinra also demonstrated clinically meaningful differences in key secondary endpoints of clinical remission, symptomatic remission and endoscopic improvement at week 12 versus placebo in the ANTHEM-UC study.Shares of PTGX were up 45.9% on March 10 following the announcement of the news.In the past year, shares of Protagonist have rallied 87.4% against the industry’s decline of 8.5%.The randomized, placebo-controlled phase IIb ANTHEM-UC study evaluated the safety and efficacy of thr","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ptgx-j-j-partnered-drug-161500020.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["JNJ","IE0034235303.USD","LU1061106388.HKD","IE000M9KFDE8.USD","SG9999002232.USD","LU1929549753.HKD","LU0795875086.SGD","LU1868836591.USD","LU1732800096.USD","PTGX","BK4534","LU2468319806.SGD","IE00BFXG1179.USD","LU1244550221.USD","LU1291159041.SGD","LU1674673428.USD","IE00BGHQF631.EUR","LU2129689431.USD","LU2360032135.SGD","LU2430703178.SGD","IE00BVYPNV92.GBP","LU2125154778.USD","BK4007","IE00B42XCP33.USD","LU0203347892.USD","LU1989771016.USD","LU2125154935.USD","LU2602419157.SGD","BK4588","BK4585","BMY","LU1221951046.USD","LU1914381329.SGD","BK4581","LU1023059063.AUD","BK4592","LU2133065610.SGD","LU0345770993.USD","BMRN","LU0098860793.USD","LU0792757196.USD","LU1066051498.USD","LU1323610961.USD","IE00B4R5TH58.HKD","LU1585245621.USD","LU2347655156.SGD","BK4532","IE00B2B36J28.USD","LU1244550577.SGD","LU0640476718.USD"],"gpt_icon":0},{"id":"2518445387","title":"Protagonist Therapeutics Soars as Icotrokinra Drives Breakthrough Success","url":"https://stock-news.laohu8.com/highlight/detail?id=2518445387","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518445387?lang=en_us&edition=fundamental","pubTime":"2025-03-11 21:29","pubTimestamp":1741699755,"startTime":"0","endTime":"0","summary":"March 11, 2025 - The stock of Protagonist Therapeutics  dramatically increased by 45.82% on Monday after it declared successful results from the Phase 2b ANTHEM-UC study of icotrokinra .GuruFocus has detected 5 Warning Signs with PTGX.The joint development project of Protagonist Therapeutics and Johnson & Johnson  produced Icotrokinra as their first-in-class targeted oral peptide. Icotrokinra is a pill taken orally to treat plaque psoriasis , and ulcerative colitis.Icotrokinra works by blocking the IL-23 receptor selectively and the study achieved a 63.5% clinical response at its highest dose after twelve weeks and the result is only 27% to placebo. The treatment presented a good safety outcome and showed improvement until Week 28.PTGX stands as an interesting investment material since it successfully turned around in 2024.In the biotech industry, it is quite common that in the first years the companies often face financial losses for the high cost of initial research and developments ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/protagonist-therapeutics-soars-icotrokinra-drives-132915786.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["JNJ","IE0034235303.USD","LU1061106388.HKD","IE000M9KFDE8.USD","SG9999002232.USD","LU1929549753.HKD","LU1894683264.USD","LU2089984988.USD","LU2430703095.HKD","LU1506573853.SGD","LU0795875086.SGD","LU0234572021.USD","LU1162221912.USD","IE00B1BXHZ80.USD","BK4139","LU1732800096.USD","BK4534","LU2468319806.SGD","LU1244550221.USD","LU2129689431.USD","IE0009355771.USD","LU0889566641.SGD","LU1718418525.SGD","IE00BDGV0183.EUR","BK4504","LU0203347892.USD","IE00BSNM7G36.USD","LU2129689605.HKD","LU1221951129.SGD","LU2592432038.USD","LU0882574055.USD","LU0122379950.USD","BK4588","IE0002141913.USD","BK4533","IE00BFTCPJ56.SGD","BK4592","LU0345769128.USD","LU0345770993.USD","LU0792757196.USD","LU0098860793.USD","LU1066051811.HKD","LU1066051498.USD","LU1585245621.USD","IE00B4R5TH58.HKD","PTGX","LU1244550577.SGD","LU2129689514.USD","LU2505996509.AUD","BK4550"],"gpt_icon":0},{"id":"2518749844","title":"TuHURA Biosciences, Inc Appoints Craig L. Tendler M.D., Former Vice President, Oncology Clinical Development, Diagnostics, and Global Medical Affairs, Johnson & Johnson Innovative Medicine Research & Development, to its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2518749844","media":"ACCESS Newswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518749844?lang=en_us&edition=fundamental","pubTime":"2025-03-11 20:05","pubTimestamp":1741694700,"startTime":"0","endTime":"0","summary":"Dr. Tendler oversaw 30 Major Drug Approvals, including worldwide approvals for J&J's transformational treatments in hematologic malignancies, prostate, lung and bladder cancers. Dr. Tendler also oversaw 13 FDA Breakthrough Designations accelerating the early development of promising investigational medicines intended for treatment of serious oncology indications. TAMPA, FL / ACCESS Newswire / March 11, 2025 / TuHURA Biosciences, Inc.  , a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy, today announced it has appointed Craig L. Tendler, M.D. to its Board of Directors effective March 10, 2025.Dr. Tendler added, \"TuHURA has established a science-based portfolio of novel complementary technologies and late-stage drug candidates that I believe has the potential to make a significant impact on the immuno-oncology treatment landscape. The data demonstrated to date are promising and underscore the ability of one o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tuhura-biosciences-inc-appoints-craig-120500961.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4548","SG9999011746.SGD","BK4563","JNJ","BK4552","IE00BYQNZ168.SGD","BK4565","TME","BK4535","LU0359201612.USD","IE00B12V2V27.USD","IE00BYTNYN87.SGD","BK4225","BK4571","BK4139","BK4203","LU2039709279.SGD","LU0359202008.SGD","BK4531","01698","LU1023057109.AUD","BK4108","BK4526","BK4509","HURA","GMRE"],"gpt_icon":0},{"id":"2518771704","title":"Breakfast News: The Rout Continues","url":"https://stock-news.laohu8.com/highlight/detail?id=2518771704","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518771704?lang=en_us&edition=fundamental","pubTime":"2025-03-11 19:30","pubTimestamp":1741692600,"startTime":"0","endTime":"0","summary":"Nasdaq's big one-day fall, Tesla on the ropes, big stock moves, and more...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/breakfast-news/2025/03/11/breakfast-news-the-rout-continues/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU1244550221.USD","BK4504","IE00BFTCPJ56.SGD","LU1430594728.SGD","IE00BGHQF631.EUR","LU0882574055.USD","IE00B3PB1722.GBP","LU1162221912.USD","LU2430703095.HKD","BK4568","LU1061106388.HKD","JNJ","LU1059921491.USD","IE00B4R5TH58.HKD","LU0640476718.USD","IE00B42XCP33.USD","BK4581","LU1066051498.USD","BK4585","LU0345769631.USD","BK4559","SG9999001440.SGD","LU1261432733.SGD","LU0203345920.USD","LU1267930813.SGD","IPO","LU0345770308.USD","LU2347655156.SGD","LU1244550494.USD","IE00B7SZLL34.SGD","LU1929549753.HKD","LU2430703251.USD","LU1674673691.USD","SG9999002224.SGD","LU0114720955.EUR","LU0345769128.USD","LU2112291526.USD","IE0034235303.USD","IE00BVYPNV92.GBP","GDP","LU1032466523.USD","LU2089984988.USD","LU0058720904.USD","BK4550","LU0320765646.SGD","LU0795875169.SGD","LU1221951046.USD","BK4592","LU1066051811.HKD","LU1914381329.SGD"],"gpt_icon":0},{"id":"2518748469","title":"Genmab sinks as J&J opts not to develop Darzalex successor; stock upgraded","url":"https://stock-news.laohu8.com/highlight/detail?id=2518748469","media":"Investing.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518748469?lang=en_us&edition=fundamental","pubTime":"2025-03-11 19:06","pubTimestamp":1741691214,"startTime":"0","endTime":"0","summary":"Investing.com -- Genmab   announced on Monday, March 10, that Johnson&Johnson  has chosen not to proceed with the development of GEN3014 , a next-gen version of their megablockbuster cancer drug, Darzalex.Genmab’s U.S.-listed shares closed 9% lower Monday and fell by an additional 3.6% in Tuesday’s premarket trade.GEN3014, also known as HexaBody-CD38, is an investigational monoclonal antibody developed by Genmab that targets the CD38 protein on multiple myeloma cells, enhancing immune-mediated tumor cell destruction.The company held an investor call to discuss the decision, during which it shared initial data from a head-to-head study comparing GEN3014 to Darzalex.While the results suggested potentially deeper responses, they were not compelling enough for J&J or Genmab to pursue further development of GEN3014 for other indications.Following the post-announcement stock pullback, analysts at William Blair upgraded Genmab stock to an Outperform rating.“With a steady cadence of Phase III ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/genmab-sinks-j-j-opts-110654356.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GMAB","JNJ"],"gpt_icon":0},{"id":"2518953787","title":"BUZZ-Genmab falls after J&J Hexabody opt-out","url":"https://stock-news.laohu8.com/highlight/detail?id=2518953787","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518953787?lang=en_us&edition=fundamental","pubTime":"2025-03-11 16:20","pubTimestamp":1741681247,"startTime":"0","endTime":"0","summary":"BUZZ-Genmab falls after J&J Hexabody opt-out** Shares in Genmab GMAB.CO fall 5.4% after Johnson & Johnson JNJ.N opted out of further clinical development of the Hexabody-CD38 cancer drug on Monday** Van Lanschot Kempen says that Hexabody did not differentiate enough from Darzalex, the company's flagship drug, and neither Genmab nor J&J will take the project forward** While Kempen says \"the shares are now free to perform\" without this overhang, Jyske Bank does not expect a quick rebound but rather a slow regain of market confidence** Kempen expects continued earnings momentum and growing appreciation for another cancer drug Epkinly as a major growth driver** Genmab says J&J opt-out does not impact its 2025 guidance  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250311:nL8N3PU0BD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4559","LU0122379950.USD","LU0640476718.USD","IE00BVYPNV92.GBP","BK4585","LU0234572021.USD","BK4592","LU2505996681.GBP","JNJ","LU2129689605.HKD","SG9999002232.USD","IE00BDGV0183.EUR","IE00BGHQF631.EUR","IE00B19Z3B42.SGD","LU0882574055.USD","IE00B7SZLL34.SGD","LU1023059063.AUD","LU0889566641.SGD","LU0203345920.USD","BK4532","LU1221951129.SGD","LU2430703095.HKD","LU1074936037.SGD","LU2133065610.SGD","LU2430703251.USD","LU2592432038.USD","IE000M9KFDE8.USD","SG9999001440.SGD","IE00B3PB1722.GBP","LU1244550494.USD","LU0466842654.USD","LU2129689514.USD","IE0002141913.USD","LU1244550221.USD","LU0058720904.USD","LU0792757196.USD","LU1280957306.USD","LU2505996509.AUD","LU1059921491.USD","LU1267930813.SGD","IE00BJJMRZ35.SGD","LU1261432733.SGD","BK4534","LU1935042991.SGD","IE0009355771.USD","LU0289739699.SGD","LU1718418525.SGD","BK4007","LU1066051498.USD","LU0234570918.USD"],"gpt_icon":0},{"id":"2518762071","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: BridgeBio Pharma (BBIO), Johnson & Johnson (JNJ) and Lexicon Pharmaceuticals (LXRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2518762071","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518762071?lang=en_us&edition=fundamental","pubTime":"2025-03-11 15:31","pubTimestamp":1741678265,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on BridgeBio Pharma (BBIO – Research Report), Johnson...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-bridgebio-pharma-bbio-johnson-johnson-jnj-and-lexicon-pharmaceuticals-lxrx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-bridgebio-pharma-bbio-johnson-johnson-jnj-and-lexicon-pharmaceuticals-lxrx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1935042991.SGD","IE00B4R5TH58.HKD","BK4139","LU2129689514.USD","BBIO","LU1066053197.SGD","LU1718418525.SGD","IE0002141913.USD","IE00BDGV0183.EUR","LU0114720955.EUR","IE00B3PB1722.GBP","LU1674673691.USD","SG9999002232.USD","LU0795875086.SGD","BK4534","LU0889566641.SGD","LU1280957306.USD","LU0098860793.USD","JNJ","LU1267930813.SGD","LXRX","LU0345770308.USD","LU0882574055.USD","IE00BJT1NW94.SGD","BK4007","BK4533","BK4504","IE00B19Z3B42.SGD","LU1059921491.USD","LU1244550577.SGD","BK4559","LU0792757196.USD","LU1162221912.USD","IE0034235303.USD","LU1914381329.SGD","LU2430703251.USD","BK4585","LU0234570918.USD","IE00BVYPNV92.GBP","LU1894683348.USD","BK4581","HCSG","LU1778281490.HKD","LU0234572021.USD","LU0345769631.USD","LU2430703095.HKD","LU1261432733.SGD","LU1732800096.USD","BK4550","LU1023059063.AUD"],"gpt_icon":0},{"id":"2518733224","title":"Are High-Yield Dividend Stocks Best for Income-Focused Investors?","url":"https://stock-news.laohu8.com/highlight/detail?id=2518733224","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518733224?lang=en_us&edition=fundamental","pubTime":"2025-03-11 07:04","pubTimestamp":1741647840,"startTime":"0","endTime":"0","summary":"When selecting dividend-paying stocks, one of the first things that investors look at is, of course, the annual yield.But are high-yield stocks always the best route for income-focused investors?At a quick glance, a dividend-paying stock with a steep annual yield indeed seems like a solid investment from an income-focused standpoint. This is particularly true from a shorter-term perspective, but it’s not always that simple and clear-cut.The risk to the initial investment is often greater in these situations, given the already negative sentiment causing poor price action. Remember, stocks can always go lower than previously thought, and you don’t want to get trapped in bearish price action.But for those who seek reliability, targeting companies that have a rich history of increasing payouts are prime considerations. Dividend Aristocrats reflect these companies, as companies in the club have upped their dividend payouts for a minimum of 25 consecutive years and are included in the S&P 50","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/high-yield-dividend-stocks-best-230400738.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0234570918.USD","LU2347655156.SGD","LU0289739699.SGD","LU2129689514.USD","BK4568","LU0792757196.USD","LU1585245621.USD","LU0640476718.USD","IE00B3PB1722.GBP","LU0345770993.USD","US12M.BOND","IE00B19Z3B42.SGD","US2Y.BOND","IE00B19Z3581.USD","BK4588","LU1023059063.AUD","LU0795875169.SGD","LU0203347892.USD","LU1670710661.SGD","US30Y.BOND","LU2360032135.SGD","LU1074936037.SGD","US6M.BOND","LU1162221912.USD","KO","LU1066051811.HKD","PG","IE00BVYPNV92.GBP","LU1066051498.USD","US10Y.BOND","ISBC","LU2237443549.SGD","LU1868836757.USD","US5Y.BOND","LU0094547139.USD","IE0002141913.USD","LU2112291526.USD","LU2552382058.USD","JNJ","LU2129689605.HKD","US7Y.BOND","LU2592432038.USD","LU1670711040.USD","LU0124676726.USD","LU1732799900.SGD","IE00BJJMRZ35.SGD","US3Y.BOND","LU1057294990.SGD","LU0689626769.HKD","LU0061475181.USD"],"gpt_icon":1},{"id":"2518202403","title":"How Exxon Mobil, Johnson & Johnson, And Cogent Communications Can Put Cash In Your Pocket","url":"https://stock-news.laohu8.com/highlight/detail?id=2518202403","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518202403?lang=en_us&edition=fundamental","pubTime":"2025-03-11 03:30","pubTimestamp":1741635018,"startTime":"0","endTime":"0","summary":"Exxon Mobil Corporation  engages in the exploration and production of crude oil and natural gas in the U.S. and internationally.Exxon Mobil has raised its dividends every year for the last 42 years. According to its most recent dividend hike announcement on Nov. 1, the company increased the quarterly payout by 4% to $0.99 per share, which is equal to an annual figure of $3.96 per share. The current dividend yield is 3.76%.Exxon Mobil’s annual revenue as of Dec. 31 stood at $339.25 billion. In its Q4 2024 earnings release on Jan. 31, the company posted quarterly revenues of $83.43 billion, missing the consensus estimate of $87.20 billion, while EPS of $1.67 came in above the consensus of $1.55.If you invested $10,000 in Exxon Mobil stock 10 years ago, how much would you have now?Cogent Communications has increased its dividend consecutively for the last 13 years. As per the company's most recent dividend announcement on Feb. 27, its board of directors raised the quarterly payout by $0.0","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exxon-mobil-johnson-johnson-cogent-193018690.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0109392836.USD","LU2456880835.USD","LU2077746001.SGD","IE00BWXC8680.SGD","IE00BBT3K403.USD","LU0096364046.USD","IE0003U64NQ7.SGD","LU0345768740.USD","BK4570","IE00B19Z3581.USD","LU0654597011.USD","LU0198837287.USD","TSYW.SI","BK4588","CCOI","IE00B7SZLL34.SGD","LU1629891620.HKD","LU1732799900.SGD","BK4507","SG9999001440.SGD","LU0456855351.SGD","LU1868837300.USD","LU1066053197.SGD","LU2083900584.USD","BK4581","LU1894683348.USD","LU0354030511.USD","LU1934455194.USD","BK4585","IE00BJTD4V19.USD","LU1037948541.HKD","LU1670627923.USD","LU1032466523.USD","LU1242518857.USD","LU2247934214.USD","IE00B3CCJ963.GBP","LU0672654240.SGD","LU1839511570.USD","LU2290526834.HKD","XOM","MACW.SI","LU1066051811.HKD","JNJ","IE00B1BXHZ80.USD","BK4534","LU2756315664.SGD","IE000M9KFDE8.USD","LU2125154935.USD"],"gpt_icon":1},{"id":"2518202266","title":"Johnson & Johnson's Ulcerative Colitis Drug Hits Key Trial Goals, Stock Rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2518202266","media":"GuruFocus.com","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518202266?lang=en_us&edition=fundamental","pubTime":"2025-03-11 03:14","pubTimestamp":1741634094,"startTime":"0","endTime":"0","summary":"Johnson & Johnson  announced Monday that its oral treatment, icotrokinra, met the main goal in a mid-stage trial for ulcerative colitis, boosting JNJ stock by 1% in early trading.The study evaluated icotrokinra, a targeted oral peptide that blocks the IL-23 receptor, in adults with moderate to severe ulcerative colitis. Results showed positive responses across all tested doses, with the drug also meeting secondary goals, including clinical remission, symptom reduction, and endoscopic improvement.At Week 12, 63.5% of patients on the highest dose showed improvement, compared to 27% in the placebo group. Additionally, 30.2% of patients on the highest dose achieved clinical remission, versus 11.1% on placebo, according to JNJ.The company also noted that icotrokinra was well tolerated, with similar side effect rates between the treatment and placebo groups. These results position JNJ's investigational drug as a potential new option for ulcerative colitis patients seeking effective oral trea","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/johnson-johnsons-ulcerative-colitis-drug-191454869.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2468319806.SGD","LU0345769631.USD","BK4504","IE00B7SZLL34.SGD","IE000M9KFDE8.USD","IE0009355771.USD","LU1032955483.USD","BK4550","LU0345770993.USD","LU1718418525.SGD","IE00B19Z3B42.SGD","IE00B4R5TH58.HKD","LU2430703251.USD","BK4585","LU0203347892.USD","LU1059921491.USD","LU2133065610.SGD","LU1244550494.USD","IE0002141913.USD","LU0098860793.USD","IE00BGHQF631.EUR","LU1032466523.USD","IE00B19Z3581.USD","JNJ","LU1261432733.SGD","LU0882574055.USD","LU1280957306.USD","LU1023059063.AUD","SG9999001440.SGD","BK4559","LU2430703095.HKD","IE0002270589.USD","BK4588","LU2112291526.USD","LU1894683348.USD","LU0466842654.USD","LU1674673428.USD","IE00B1BXHZ80.USD","IE00BFTCPJ56.SGD","BK4534","LU0203345920.USD","LU1066051225.USD","LU1066051811.HKD","IE0034235303.USD","BK4581","LU1162221912.USD","IE00B3PB1722.GBP","LU1066053197.SGD","LU2430703178.SGD","LU1732799900.SGD"],"gpt_icon":1},{"id":"2518520936","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2518520936","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518520936?lang=en_us&edition=fundamental","pubTime":"2025-03-11 02:28","pubTimestamp":1741631308,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics (MLYS) said Monday that lorundrostat met primary endpoints in phase 3 Launch-HTN and phase 2 Advance-HTN trials in patients with uncontrolled hypertension or resistant hypertens","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1074936037.SGD","LU2592432038.USD","BK4559","IE00BGHQF631.EUR","IE00BJJMRZ35.SGD","LU1023059063.AUD","BK4585","LU1057294990.SGD","BK4139","LU2347655156.SGD","RDFN","LU0345770308.USD","BK4007","RKT.AU","LU1059921491.USD","BK4581","LU1061106388.HKD","LU0795875086.SGD","MLYS","BK4568","LU2430703251.USD","BK4533","BK7084","BK4504","LU1674673428.USD","LU1674673691.USD","BK4532","LU0640476718.USD","BK4592","JNJ","PTGX","IE00B2B36J28.USD","LU1778281490.HKD","LU0289739699.SGD","LU1894683264.USD","IE00B4R5TH58.HKD","LU1196500208.SGD","LU1267930813.SGD","IE00B3PB1722.GBP","LU1732799900.SGD","BK4079","LU2129689431.USD","RKT","SG9999001440.SGD","LU0203347892.USD","IE000M9KFDE8.USD","LU0345769128.USD","IE00B19Z3581.USD","BK4588","LU1244550494.USD"],"gpt_icon":1},{"id":"2518062192","title":"Eli Lilly CEO David Ricks' pay rose to almost $30 million in 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2518062192","media":"Quartz","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518062192?lang=en_us&edition=fundamental","pubTime":"2025-03-11 01:16","pubTimestamp":1741626983,"startTime":"0","endTime":"0","summary":"David Ricks, Chair and C.E.O. of Eli Lilly and Company, speaks during the New York Times annual DealBook summit at Jazz at Lincoln Center on December 04, 2024 in New York City. - Image: Michael M. Santiago / Staff . Eli Lilly  CEO David Ricks got a 10% raise in 2024, as a surge in demand for weigh-loss drugs has propelled the pharma giant into the most valuable pharmaceutical company in the world.Ricks’ total compensation for 2024 reached $29.2 million, according to the company’s latest proxy statement, up from $26.6 million in 2023. When he became CEO in 2017, Ricks’ annual compensation started at $15.8 million.In that time, Eli Lilly has seen explosive growth, largely due to its blockbuster diabetes and weight-loss drugs, Mounjaro and Zepbound.Mounjaro brought in $11.5 billion in sales in 2024, while Zepbound generated $4.9 billion in annual revenue.The company’s strong performance has also boosted its stock price. Eli Lilly’s stock has climbed 10% over the past 12 months to about $8","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/eli-lilly-ceo-david-ricks-171623903.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SGXZ31699556.SGD","LU2362541513.USD","JNJ","LU1674673691.USD","LU0861579265.USD","LU0965509283.SGD","LU0456855351.SGD","LU1267930227.SGD","LU1989772840.SGD","LU1069344957.HKD","IE00B19Z9505.USD","LU1548497426.USD","SG9999018865.SGD","LU0528227936.USD","IE00B19Z9P08.USD","LU0310799852.SGD","LU1003077747.HKD","LU0820562030.AUD","SG9999001176.USD","LU0820561909.HKD","LU2362541273.HKD","IE00BJJMRY28.SGD","LU2106854487.HKD","LU2244417387.USD","LU0820561818.USD","LU0976567544.SGD","LU0787776722.HKD","LU2125154778.USD","LU2237443895.HKD","LU1093756168.USD","IE00BFSS7M15.SGD","LLY","LU0965509010.AUD","LU1037948541.HKD","SG9999002232.USD","LU2237443465.HKD","LU2063271972.USD","BK4568","LU0096364046.USD","IE00B19Z8X17.USD","LU0109391861.USD","SG9999014898.SGD","LU2491050071.SGD","LU1551013425.SGD","LU1732800096.USD","LU1989772923.USD","BK4007","LU0006306889.USD"],"gpt_icon":1},{"id":"2518620815","title":"BRIEF-Genmab Says Johnson & Johnson Will Not Exercise Option For Hexabody-Cd38 License","url":"https://stock-news.laohu8.com/highlight/detail?id=2518620815","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518620815?lang=en_us&edition=fundamental","pubTime":"2025-03-11 01:08","pubTimestamp":1741626499,"startTime":"0","endTime":"0","summary":"BRIEF-Genmab Says Johnson & Johnson Will Not Exercise Option For Hexabody-Cd38 LicenseMarch 10 (Reuters) - Genmab A/S GMAB.CO:GENMAB ANNOUNCES JOHNSON & JOHNSON DECISION REGARDING HEXABODY-CD38GENMAB ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nTUA8D268K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","LU0889566641.SGD","IE000M9KFDE8.USD","LU0345769128.USD","IE00BVYPNV92.GBP","LU1023059063.AUD","LU1894683348.USD","LU1261432733.SGD","LU0466842654.USD","IE00BJT1NW94.SGD","JNJ","IE00BVYPNW00.USD","LU1066051225.USD","LU1506573853.SGD","IE00B2B36J28.USD","LU2430703178.SGD","LU2112291526.USD","LU1032466523.USD","LU2505996681.GBP","LU1732800096.USD","LU0882574055.USD","BK4007","LU1674673428.USD","LU2133065610.SGD","LU1074936037.SGD","LU0912757837.SGD","IE00BJJMRZ35.SGD","LU2129689605.HKD","IE00BGHQF631.EUR","LU0234570918.USD","IE0002141913.USD","LU1280957306.USD","LU0792757196.USD","LU1244550494.USD","LU1894683264.USD","BK4592","LU0795875169.SGD","IE00BDGV0183.EUR","LU0640476718.USD","LU1732799900.SGD","BK4585","LU1162221912.USD","LU1057294990.SGD","IE00B42XCP33.USD","LU1066051498.USD","IE0009355771.USD","SG9999002224.SGD","LU1059921491.USD","LU2347655156.SGD","LU1066051811.HKD"],"gpt_icon":0},{"id":"2518313270","title":"Expectations for J&J Genmab opt-in lowered ahead of news, says Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2518313270","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518313270?lang=en_us&edition=fundamental","pubTime":"2025-03-11 00:36","pubTimestamp":1741624598,"startTime":"0","endTime":"0","summary":"Morgan Stanley says intra-day pressure on Genmab (GMAB) of greater than 5% after Genmab announced that partner Johnson & Johnson (JNJ) has decided ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/expectations-for-jj-genmab-opt-in-lowered-ahead-of-news-says-morgan-stanley?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/expectations-for-jj-genmab-opt-in-lowered-ahead-of-news-says-morgan-stanley?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2468319806.SGD","BK4504","IE00B7SZLL34.SGD","LU1506573853.SGD","LU0158827948.USD","LU1032955483.USD","LU1548497426.USD","BK4550","LU2505996681.GBP","LU2271345857.HKD","IE00B19Z3B42.SGD","IE00B2B36J28.USD","LU0889566641.SGD","BK4585","LU0640476718.USD","LU1059921491.USD","LU1244550494.USD","IE00BVYPNV92.GBP","IE00BGHQF631.EUR","LU2089283258.USD","SG9999002232.USD","JNJ","LU2357305700.SGD","LU0882574055.USD","SG9999001440.SGD","IE0002270589.USD","GMAB","LU2112291526.USD","BK4533","LU0345770308.USD","LU0912757837.SGD","IE00B1BXHZ80.USD","BK4534","LU2023251221.USD","LU1066051225.USD","LU2129689431.USD","LU1066051811.HKD","LU1989772840.SGD","IE0034235303.USD","LU0234572021.USD","BK4581","LU1162221912.USD","BK4007","LU1674673691.USD","LU1894683264.USD","BK4127","IE00BVYPNW00.USD","LU1929549753.HKD","LU1732799900.SGD","LU2111349929.HKD"],"gpt_icon":0},{"id":"2518271869","title":"Genmab’s HexaBody-CD38 Development Halted After J&J Decision","url":"https://stock-news.laohu8.com/highlight/detail?id=2518271869","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518271869?lang=en_us&edition=fundamental","pubTime":"2025-03-10 23:16","pubTimestamp":1741619817,"startTime":"0","endTime":"0","summary":"Genmab ( ($GMAB) ) has shared an announcement. On March 10, 2025, Genmab A/S announced that Johnson & Johnson decided not to exercise its option to...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/genmabs-hexabody-cd38-development-halted-after-jj-decision?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/genmabs-hexabody-cd38-development-halted-after-jj-decision?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2430703251.USD","IE00B1BXHZ80.USD","BK4534","LU1914381329.SGD","BK4581","IE00B42XCP33.USD","LU2133065610.SGD","BK4504","LU0345770993.USD","LU2089984988.USD","IE00BGHQF631.EUR","LU1430594728.SGD","LU1244550577.SGD","BK4533","LU2468319806.SGD","SG9999002232.USD","LU1244550494.USD","LU1221951046.USD","LU1059921491.USD","LU2592432038.USD","LU1066051498.USD","IE00B19Z3B42.SGD","LU0058720904.USD","LU0203345920.USD","LU0466842654.USD","IE00BFTCPJ56.SGD","LU0889566641.SGD","LU1066051225.USD","LU1894683264.USD","BK4568","IE00BJT1NW94.SGD","LU1506573853.SGD","LU0345770308.USD","LU2112291526.USD","IE000M9KFDE8.USD","IE00B3PB1722.GBP","LU1280957306.USD","LU0122379950.USD","JNJ","LU1066053197.SGD","LU1718418525.SGD","LU0640476718.USD","LU2129689605.HKD","IE00BSNM7G36.USD","IE00B7SZLL34.SGD","IE00B4R5TH58.HKD","LU1732799900.SGD","LU0882574055.USD","IE0009355771.USD","BK4550"],"gpt_icon":0},{"id":"2518795012","title":"BRIEF-J&J's oral drug to treat inflammation-causing condition in colon meets main goal in mid-stage study","url":"https://stock-news.laohu8.com/highlight/detail?id=2518795012","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518795012?lang=en_us&edition=fundamental","pubTime":"2025-03-10 23:12","pubTimestamp":1741619554,"startTime":"0","endTime":"0","summary":"BRIEF-J&J's oral drug to treat inflammation-causing condition in colon meets main goal in mid-stage studyMarch 10  - Johnson & Johnson JNJ.N:ICOTROKINRA MEETS PRIMARY ENDPOINT OF CLINICAL RESPONSE IN ULCERATIVE COLITIS STUDY AND SHOWS POTENTIAL TO TRANSFORM THE TREATMENT PARADIGM FOR PATIENTSJ&J: ICOTROKINRA WAS WELL TOLERATEDSource text: nPn7xsC0haFurther company coverage: JNJ.N ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nFWN3PT10C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0792757196.USD","IE00B1BXHZ80.USD","LU1032955483.USD","LU1506573853.SGD","JNJ","LU1914381329.SGD","LU0889566641.SGD","LU2430703095.HKD","IE0002270589.USD","LU2129689514.USD","LU1261432733.SGD","BK4581","LU1732799900.SGD","LU0058720904.USD","SG9999002232.USD","LU1074936037.SGD","SG9999001440.SGD","LU1066051498.USD","IE00BDGV0183.EUR","LU2129689605.HKD","LU2129689431.USD","LU1066051811.HKD","BK4550","BK4559","LU1221951129.SGD","LU0882574055.USD","LU2602419157.SGD","LU2505996681.GBP","LU1430594728.SGD","LU0795875169.SGD","LU2112291526.USD","IE00B19Z3581.USD","IE00B7SZLL34.SGD","IE00B19Z3B42.SGD","IE00BGHQF631.EUR","BK4585","LU0345769631.USD","BK4007","LU2133065610.SGD","LU1585245621.USD","IE00B3PB1722.GBP","LU1196500208.SGD","BK4532","BK4588","LU1066053197.SGD","LU0203347892.USD","IE00BSNM7G36.USD","LU0345770308.USD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"2518277123","title":"Zacks Investment Ideas feature highlights: Coca-Cola, Philip Morris and Johnson & Johnson","url":"https://stock-news.laohu8.com/highlight/detail?id=2518277123","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518277123?lang=en_us&edition=fundamental","pubTime":"2025-03-10 23:06","pubTimestamp":1741619160,"startTime":"0","endTime":"0","summary":"Chicago, IL – March 10, 2025– Today, Zacks Investment Ideas feature highlights Coca-Cola KO, Philip Morris PM and Johnson & Johnson JNJ.The market has thrown a tantrum over recent weeks following tariff news and other economic data pointing to a slowing consumer. While it's certainly been a forgettable period, several stocks, including Coca-Cola, Philip Morris and Johnson & Johnson, have remained strong over the past month.All three reflect defensive deployments, with their products able to carry steady demand through many economic backdrops. Let's take a closer look at each for those interested in adding in an additional layer of defense.Concerning headline figures in KO's latest release, the company exceeded both consensus EPS and sales expectations handily, reflecting growth rates of 12% and 6%, respectively. Notably, the company's gross margin has remained constructive over recent periods, recovering nicely from early 2023 lows.Like those above, the stock is a prime selection for t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zacks-investment-ideas-feature-highlights-150600780.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1280957306.USD","LU2237957811.SGD","IE00BLSP4239.USD","LU0323591593.USD","LU1064131342.USD","LU1066053197.SGD","LU2129689605.HKD","LU1066051498.USD","LU0823417653.USD","LU0661504455.SGD","JNJ","LU2506951875.HKD","IE00BJT1NW94.SGD","PM","BK4075","KO","LU0795875086.SGD","LU0823417737.USD","IE00B2B36J28.USD","IE00B1BXHZ80.USD","LU2279689827.SGD","LU1066051811.HKD","LU0640476718.USD","IE00B19Z3B42.SGD","LU0994945656.USD","LU0426412945.USD","LU1066051225.USD","SG9999014542.SGD","IE00B4R5TH58.HKD","IE0034235303.USD","LU0265550359.USD","LU1732799900.SGD","LU0690374615.EUR","IE0002141913.USD","LU0289739699.SGD","LU0957791311.USD","LU1244550577.SGD","SFB","BK4177","LU1023059063.AUD","IE00BVYPNW00.USD","LU2404859667.USD","LU1674673428.USD","LU0234572021.USD","LU1914381329.SGD","LU1267930813.SGD","LU1778281490.HKD","LU1244550221.USD","BK4504","LU0114720955.EUR"],"gpt_icon":1}],"pageSize":20,"totalPage":20,"pageCount":20,"totalSize":400,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/JNJ\",params:#limit:5,,,undefined,":[{"date":"2025-05-27","symbol":"JNJ","amount":1.3,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-27","defaultRemindTime":1748352600000,"name":"强生","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-10","payableDate":"2025-05-27","currency":"USD","dateTimestamp":1748318400000,"payDate":"2025-06-10"},{"market":"US","date":"2025-04-15","symbol":"JNJ","fiscalQuarterEnding":"2025/03","expectedEps":2.57,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1744689600000,"reportTimeType":"pre","actualEps":2.77},{"date":"2025-02-18","symbol":"JNJ","amount":1.24,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-18","defaultRemindTime":1739889000000,"name":"强生","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-04","payableDate":"2025-02-18","currency":"USD","dateTimestamp":1739854800000,"payDate":"2025-03-04"},{"market":"US","date":"2025-01-22","symbol":"JNJ","fiscalQuarterEnding":"2024/12","expectedEps":2,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1737522000000,"reportTimeType":"pre","actualEps":2.04},{"date":"2024-11-26","symbol":"JNJ","amount":1.24,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-11-26","defaultRemindTime":1732631400000,"name":"强生","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-10","payableDate":"2024-11-26","currency":"USD","dateTimestamp":1732597200000,"payDate":"2024-12-10"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"JNJ\",market:\"US\",,,undefined,":[{"executeDate":"2015-05-21","recordDate":"2015-05-26","paymentDate":"2015-06-09","value":0.75,"currency":"USD"},{"executeDate":"2015-08-21","recordDate":"2015-08-25","paymentDate":"2015-09-08","value":0.75,"currency":"USD"},{"executeDate":"2015-11-20","recordDate":"2015-11-24","paymentDate":"2015-12-08","value":0.75,"currency":"USD"},{"executeDate":"2016-02-19","recordDate":"2016-02-23","paymentDate":"2016-03-08","value":0.75,"currency":"USD"},{"executeDate":"2016-05-20","recordDate":"2016-05-24","paymentDate":"2016-06-07","value":0.8,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"JNJ\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1923,"buy":0.2692,"hold":0.5385,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2692,"analysts":26,"updateTime":1744171200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/JNJ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"JNJ","date":"2025-04-28","current":17.053224,"percent":0.187344,"low":8.579006,"twenty":20.960139,"median":23.911734,"eighty":27.898419,"high":36.412821,"avg":22.727371,"sd":6.734779,"marketCap":371930807467},"quantilePoints":[{"date":"2020-05-01","current":22.759176,"twenty":18.735775,"median":23.109347,"eighty":27.599044,"marketCap":390684023595},{"date":"2020-05-08","current":22.822102,"twenty":19.127953,"median":23.109347,"eighty":27.599044,"marketCap":391764207354},{"date":"2020-05-15","current":23.089153,"twenty":19.382974,"median":23.109347,"eighty":27.599044,"marketCap":396348401845},{"date":"2020-05-22","current":22.157545,"twenty":19.475347,"median":23.109347,"eighty":27.599044,"marketCap":380356413017},{"date":"2020-05-29","current":22.829776,"twenty":19.5115,"median":23.109347,"eighty":27.599044,"marketCap":391895937081},{"date":"2020-06-05","current":22.607234,"twenty":19.590503,"median":23.109347,"eighty":27.599044,"marketCap":388075775005},{"date":"2020-06-12","current":21.816825,"twenty":19.649079,"median":23.109347,"eighty":27.599044,"marketCap":374507613150},{"date":"2020-06-19","current":22.074667,"twenty":19.775373,"median":23.109347,"eighty":27.599044,"marketCap":378933731969},{"date":"2020-06-26","current":21.150732,"twenty":19.950076,"median":23.109347,"eighty":27.599044,"marketCap":363073472868},{"date":"2020-07-02","current":21.635721,"twenty":19.98339,"median":23.109347,"eighty":27.599044,"marketCap":371398791598},{"date":"2020-07-10","current":21.85059,"twenty":20.011787,"median":23.109347,"eighty":27.599044,"marketCap":375087223947},{"date":"2020-07-17","current":25.912196,"twenty":20.076078,"median":23.131106,"eighty":27.599044,"marketCap":393476693802},{"date":"2020-07-24","current":25.681516,"twenty":20.125159,"median":23.159117,"eighty":27.599044,"marketCap":389973813117},{"date":"2020-07-31","current":25.272331,"twenty":20.149539,"median":23.193752,"eighty":27.599044,"marketCap":383760349716},{"date":"2020-08-07","current":25.764739,"twenty":20.181909,"median":23.222825,"eighty":27.599044,"marketCap":391237568385},{"date":"2020-08-14","current":25.702321,"twenty":20.22081,"median":23.257402,"eighty":27.599044,"marketCap":390289751934},{"date":"2020-08-21","current":26.486013,"twenty":20.241265,"median":23.27709,"eighty":27.599044,"marketCap":402190114041},{"date":"2020-08-28","current":26.638591,"twenty":20.271241,"median":23.306845,"eighty":27.599044,"marketCap":404506998699},{"date":"2020-09-04","current":25.763006,"twenty":20.293663,"median":23.353075,"eighty":27.599044,"marketCap":391211240150},{"date":"2020-09-11","current":25.622565,"twenty":20.348379,"median":23.394637,"eighty":27.599044,"marketCap":389078653135},{"date":"2020-09-18","current":25.865302,"twenty":20.493086,"median":23.413631,"eighty":27.599044,"marketCap":392764606000},{"date":"2020-09-25","current":25.254993,"twenty":20.589134,"median":23.432295,"eighty":27.599044,"marketCap":383497067368},{"date":"2020-10-02","current":25.355555,"twenty":20.66024,"median":23.457245,"eighty":27.599044,"marketCap":385024104984},{"date":"2020-10-09","current":26.175658,"twenty":20.718013,"median":23.519753,"eighty":27.599044,"marketCap":397477360020},{"date":"2020-10-16","current":22.955443,"twenty":20.777568,"median":23.52089,"eighty":27.599044,"marketCap":389921156647},{"date":"2020-10-23","current":22.509743,"twenty":20.802059,"median":23.52089,"eighty":27.599044,"marketCap":382350497681},{"date":"2020-10-30","current":21.249731,"twenty":20.852405,"median":23.52089,"eighty":27.599044,"marketCap":360947925757},{"date":"2020-11-06","current":22.046344,"twenty":20.90683,"median":23.52089,"eighty":27.599044,"marketCap":374479195092},{"date":"2020-11-13","current":23.231964,"twenty":20.932588,"median":23.52089,"eighty":27.599044,"marketCap":394618146532},{"date":"2020-11-20","current":22.683324,"twenty":20.94836,"median":23.52089,"eighty":27.599044,"marketCap":385298945473},{"date":"2020-11-27","current":22.317564,"twenty":20.961808,"median":23.52089,"eighty":27.599044,"marketCap":379086144768},{"date":"2020-12-04","current":23.289308,"twenty":20.97761,"median":23.52089,"eighty":27.599044,"marketCap":395592187321},{"date":"2020-12-11","current":23.704663,"twenty":21.021529,"median":23.531213,"eighty":27.599044,"marketCap":402647401682},{"date":"2020-12-18","current":23.946436,"twenty":21.042546,"median":23.534826,"eighty":27.599044,"marketCap":406754168250},{"date":"2020-12-24","current":23.630271,"twenty":21.070826,"median":23.548153,"eighty":27.599044,"marketCap":401383781199},{"date":"2020-12-31","current":24.391238,"twenty":21.097347,"median":23.558663,"eighty":27.599044,"marketCap":414309565719},{"date":"2021-01-08","current":24.803493,"twenty":21.111621,"median":23.586469,"eighty":27.599044,"marketCap":421312129226},{"date":"2021-01-15","current":24.843788,"twenty":21.147258,"median":23.595957,"eighty":27.599044,"marketCap":421996590321},{"date":"2021-01-22","current":25.347483,"twenty":21.183404,"median":23.599747,"eighty":27.599044,"marketCap":430552354005},{"date":"2021-01-29","current":29.186264,"twenty":21.19897,"median":23.614272,"eighty":30.081908,"marketCap":429446686083},{"date":"2021-02-05","current":29.422431,"twenty":21.226117,"median":23.637028,"eighty":30.081908,"marketCap":432921642410},{"date":"2021-02-12","current":29.803518,"twenty":21.248794,"median":23.655744,"eighty":30.081908,"marketCap":438528958301},{"date":"2021-02-19","current":29.159427,"twenty":21.257145,"median":23.669632,"eighty":30.081908,"marketCap":429051804682},{"date":"2021-02-26","current":28.309134,"twenty":21.271585,"median":23.6918,"eighty":30.081908,"marketCap":416540604911},{"date":"2021-03-05","current":27.887517,"twenty":21.285637,"median":23.70506,"eighty":30.12771,"marketCap":410336920526},{"date":"2021-03-12","current":28.556475,"twenty":21.311821,"median":23.72791,"eighty":30.12771,"marketCap":420179968572},{"date":"2021-03-19","current":28.635202,"twenty":21.329473,"median":23.741859,"eighty":30.12771,"marketCap":421338359462},{"date":"2021-03-26","current":29.510146,"twenty":21.34329,"median":23.767845,"eighty":30.081908,"marketCap":434212294590},{"date":"2021-04-01","current":29.134403,"twenty":21.35594,"median":23.773685,"eighty":30.081908,"marketCap":428683610793},{"date":"2021-04-09","current":28.851701,"twenty":21.4211,"median":23.786177,"eighty":30.12771,"marketCap":424523934412},{"date":"2021-04-16","current":29.028837,"twenty":21.428126,"median":23.790128,"eighty":30.12771,"marketCap":427130313916},{"date":"2021-04-23","current":28.830009,"twenty":21.447349,"median":23.796452,"eighty":30.12771,"marketCap":435765591466},{"date":"2021-04-30","current":28.351474,"twenty":21.475831,"median":23.817885,"eighty":30.12771,"marketCap":428532531568},{"date":"2021-05-07","current":29.356747,"twenty":21.503927,"median":23.841105,"eighty":30.12771,"marketCap":443727226505},{"date":"2021-05-14","current":29.656412,"twenty":21.531317,"median":23.877391,"eighty":30.12771,"marketCap":448256667630},{"date":"2021-05-21","current":29.785338,"twenty":21.561813,"median":23.895323,"eighty":30.12771,"marketCap":450205380672},{"date":"2021-05-28","current":29.487415,"twenty":21.592765,"median":23.937312,"eighty":30.12771,"marketCap":445702273507},{"date":"2021-06-04","current":28.91596,"twenty":21.615414,"median":23.966133,"eighty":30.12771,"marketCap":437064734617},{"date":"2021-06-11","current":28.739994,"twenty":21.638518,"median":24.015189,"eighty":30.12771,"marketCap":434405004654},{"date":"2021-06-18","current":28.220806,"twenty":21.670392,"median":24.039278,"eighty":30.12771,"marketCap":426557484565},{"date":"2021-06-25","current":28.609326,"twenty":21.861141,"median":24.084813,"eighty":30.12771,"marketCap":432429957652},{"date":"2021-07-02","current":29.440374,"twenty":21.936844,"median":24.121091,"eighty":30.12771,"marketCap":444991256586},{"date":"2021-07-09","current":29.574527,"twenty":21.9912,"median":24.15923,"eighty":30.12771,"marketCap":447018971509},{"date":"2021-07-16","current":29.287057,"twenty":22.008978,"median":24.192461,"eighty":30.12771,"marketCap":442673868104},{"date":"2021-07-23","current":25.462436,"twenty":22.072979,"median":24.243827,"eighty":30.12771,"marketCap":452391099355},{"date":"2021-07-30","current":25.514348,"twenty":22.099856,"median":24.305908,"eighty":30.12771,"marketCap":453313416242},{"date":"2021-08-06","current":25.64918,"twenty":22.156186,"median":24.365597,"eighty":30.12771,"marketCap":455708974946},{"date":"2021-08-13","current":26.114424,"twenty":22.208673,"median":24.40122,"eighty":30.12771,"marketCap":463974968715},{"date":"2021-08-20","current":26.587076,"twenty":22.280598,"median":24.437878,"eighty":30.12771,"marketCap":472372586588},{"date":"2021-08-27","current":25.62251,"twenty":22.31426,"median":24.507475,"eighty":30.12771,"marketCap":455235128169},{"date":"2021-09-03","current":25.935142,"twenty":22.403746,"median":24.626763,"eighty":30.12771,"marketCap":460789665383},{"date":"2021-09-10","current":24.739435,"twenty":22.438026,"median":24.721919,"eighty":30.12771,"marketCap":439545534901},{"date":"2021-09-17","current":24.410504,"twenty":22.494978,"median":24.721919,"eighty":30.12771,"marketCap":433701424657},{"date":"2021-09-24","current":24.352719,"twenty":22.531175,"median":24.721919,"eighty":30.12771,"marketCap":432674756641},{"date":"2021-10-01","current":23.776349,"twenty":22.581732,"median":24.721919,"eighty":30.12771,"marketCap":422434401303},{"date":"2021-10-08","current":23.844506,"twenty":22.600481,"median":24.721919,"eighty":30.12771,"marketCap":423645343065},{"date":"2021-10-15","current":23.899328,"twenty":22.647017,"median":24.721919,"eighty":30.12771,"marketCap":424619361439},{"date":"2021-10-22","current":24.104584,"twenty":22.670383,"median":24.721919,"eighty":30.12771,"marketCap":430989968102},{"date":"2021-10-29","current":23.981957,"twenty":22.690905,"median":24.721919,"eighty":30.12771,"marketCap":428797394310},{"date":"2021-11-05","current":24.062938,"twenty":22.73421,"median":24.721919,"eighty":30.12771,"marketCap":430245322643},{"date":"2021-11-12","current":24.295572,"twenty":22.75379,"median":24.721919,"eighty":30.12771,"marketCap":434404825854},{"date":"2021-11-19","current":23.98343,"twenty":22.790525,"median":24.721919,"eighty":30.12771,"marketCap":428823720280},{"date":"2021-11-26","current":23.440125,"twenty":22.801141,"median":24.721919,"eighty":30.12771,"marketCap":419109437464},{"date":"2021-12-03","current":23.466628,"twenty":22.824465,"median":24.721919,"eighty":30.12771,"marketCap":419583304919},{"date":"2021-12-10","current":24.366246,"twenty":22.839493,"median":24.721919,"eighty":30.12771,"marketCap":435668472399},{"date":"2021-12-17","current":24.769675,"twenty":22.851504,"median":24.762774,"eighty":30.12771,"marketCap":442881788094},{"date":"2021-12-23","current":24.77262,"twenty":22.874439,"median":24.76352,"eighty":30.12771,"marketCap":442934440034},{"date":"2021-12-31","current":25.187828,"twenty":22.900154,"median":24.774698,"eighty":30.12771,"marketCap":450358363486},{"date":"2022-01-07","current":25.61187,"twenty":22.921295,"median":24.829881,"eighty":30.081908,"marketCap":457940242757},{"date":"2022-01-14","current":24.712253,"twenty":22.958017,"median":24.899153,"eighty":30.081908,"marketCap":441855075276},{"date":"2022-01-21","current":24.274959,"twenty":22.965167,"median":24.899153,"eighty":30.081908,"marketCap":434036262279},{"date":"2022-01-28","current":21.661741,"twenty":22.966485,"median":24.899153,"eighty":30.081908,"marketCap":452253833304},{"date":"2022-02-04","current":21.641566,"twenty":22.966485,"median":24.899153,"eighty":30.081908,"marketCap":451832617789},{"date":"2022-02-11","current":21.147276,"twenty":22.966485,"median":24.899153,"eighty":30.081908,"marketCap":441512837670},{"date":"2022-02-18","current":20.57272,"twenty":22.966485,"median":24.899153,"eighty":30.081908,"marketCap":429517246290},{"date":"2022-02-25","current":20.905188,"twenty":22.966485,"median":24.899153,"eighty":30.081908,"marketCap":436458514228},{"date":"2022-03-04","current":21.343441,"twenty":22.966485,"median":24.899153,"eighty":30.081908,"marketCap":445608367417},{"date":"2022-03-11","current":21.32707,"twenty":22.962882,"median":24.899153,"eighty":30.081908,"marketCap":445266562557},{"date":"2022-03-18","current":22.021361,"twenty":22.953432,"median":24.899153,"eighty":30.081908,"marketCap":459761966327},{"date":"2022-03-25","current":22.28334,"twenty":22.906658,"median":24.899153,"eighty":30.081908,"marketCap":465231566475},{"date":"2022-04-01","current":22.443298,"twenty":22.88299,"median":24.899153,"eighty":30.081908,"marketCap":468571178104},{"date":"2022-04-08","current":22.938288,"twenty":22.87009,"median":24.899153,"eighty":30.081908,"marketCap":478905566846},{"date":"2022-04-14","current":22.658675,"twenty":22.850073,"median":24.899153,"eighty":30.081908,"marketCap":473067820534},{"date":"2022-04-22","current":24.073645,"twenty":22.862939,"median":24.899153,"eighty":30.081908,"marketCap":477380389882},{"date":"2022-04-29","current":23.946685,"twenty":22.897881,"median":24.899153,"eighty":30.081908,"marketCap":474862769549},{"date":"2022-05-06","current":23.40395,"twenty":22.935305,"median":24.899153,"eighty":30.081908,"marketCap":464100336171},{"date":"2022-05-13","current":23.467645,"twenty":22.958017,"median":24.899153,"eighty":30.081908,"marketCap":465363409037},{"date":"2022-05-20","current":23.484896,"twenty":22.975012,"median":24.899153,"eighty":30.081908,"marketCap":465705491271},{"date":"2022-05-27","current":24.030285,"twenty":22.985845,"median":24.899153,"eighty":30.081908,"marketCap":476520552686},{"date":"2022-06-03","current":23.410585,"twenty":23.004816,"median":24.899153,"eighty":30.081908,"marketCap":464231906261},{"date":"2022-06-10","current":22.897044,"twenty":23.050406,"median":24.899153,"eighty":30.081908,"marketCap":454048381280},{"date":"2022-06-17","current":22.487007,"twenty":23.028812,"median":24.899153,"eighty":30.081908,"marketCap":445917349705},{"date":"2022-06-24","current":24.189523,"twenty":23.015811,"median":24.900273,"eighty":30.12771,"marketCap":479678234851},{"date":"2022-07-01","current":23.821949,"twenty":23.040512,"median":24.900273,"eighty":30.12771,"marketCap":472389251854},{"date":"2022-07-08","current":23.657404,"twenty":23.071416,"median":24.900273,"eighty":30.12771,"marketCap":469126313617},{"date":"2022-07-15","current":23.650769,"twenty":23.097851,"median":24.900273,"eighty":30.12771,"marketCap":468994743526},{"date":"2022-07-22","current":24.660616,"twenty":23.102569,"median":24.900273,"eighty":30.12771,"marketCap":452916878504},{"date":"2022-07-29","current":24.983365,"twenty":23.140839,"median":24.928435,"eighty":30.12771,"marketCap":458844475275},{"date":"2022-08-05","current":24.495207,"twenty":23.165705,"median":24.938619,"eighty":30.12771,"marketCap":449878971833},{"date":"2022-08-12","current":23.663478,"twenty":23.165705,"median":24.938619,"eighty":30.12771,"marketCap":434603436643},{"date":"2022-08-19","current":24.237528,"twenty":23.165705,"median":24.938619,"eighty":30.12771,"marketCap":445146448022},{"date":"2022-08-26","current":23.516029,"twenty":23.165705,"median":24.938619,"eighty":30.12771,"marketCap":431895381351},{"date":"2022-09-02","current":23.297002,"twenty":23.149852,"median":24.938619,"eighty":30.12771,"marketCap":427872736112},{"date":"2022-09-09","current":23.722171,"twenty":23.149852,"median":24.938619,"eighty":30.12771,"marketCap":435681400400},{"date":"2022-09-16","current":23.992734,"twenty":23.145303,"median":24.938619,"eighty":30.12771,"marketCap":440650550402},{"date":"2022-09-23","current":23.866758,"twenty":23.145303,"median":24.938619,"eighty":30.12771,"marketCap":438336872094},{"date":"2022-09-30","current":23.385758,"twenty":23.149852,"median":24.938619,"eighty":30.12771,"marketCap":429502827647},{"date":"2022-10-07","current":22.933389,"twenty":23.145303,"median":24.938619,"eighty":30.12771,"marketCap":421194619179},{"date":"2022-10-14","current":23.543228,"twenty":23.140839,"median":24.938619,"eighty":30.12771,"marketCap":432394925531},{"date":"2022-10-21","current":23.154405,"twenty":23.113317,"median":24.898033,"eighty":30.12771,"marketCap":443568940085},{"date":"2022-10-28","current":23.865676,"twenty":23.113317,"median":24.843788,"eighty":30.12771,"marketCap":457194748356},{"date":"2022-11-04","current":23.40302,"twenty":23.113317,"median":24.803493,"eighty":30.12771,"marketCap":448331648928},{"date":"2022-11-11","current":23.098677,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":442501350484},{"date":"2022-11-18","current":24.04719,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":460672011553},{"date":"2022-11-25","current":24.189125,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":463391074504},{"date":"2022-12-02","current":24.412947,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":467678827620},{"date":"2022-12-09","current":23.98441,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":459469349094},{"date":"2022-12-16","current":23.974857,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":459286335241},{"date":"2022-12-23","current":24.22188,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":464018550570},{"date":"2022-12-30","current":24.108604,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":461848529176},{"date":"2023-01-06","current":24.59992,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":471260670161},{"date":"2023-01-13","current":23.669149,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":453429891962},{"date":"2023-01-20","current":23.029074,"twenty":23.100329,"median":24.77262,"eighty":30.12771,"marketCap":441167963845},{"date":"2023-01-27","current":24.515611,"twenty":23.09784,"median":24.762774,"eighty":29.79261,"marketCap":439834577205},{"date":"2023-02-03","current":23.98808,"twenty":23.09784,"median":24.725504,"eighty":29.701392,"marketCap":430370146548},{"date":"2023-02-10","current":23.629592,"twenty":23.09784,"median":24.702141,"eighty":29.654503,"marketCap":423938516875},{"date":"2023-02-17","current":23.281951,"twenty":23.096013,"median":24.660616,"eighty":29.589162,"marketCap":417701480138},{"date":"2023-02-24","current":22.640351,"twenty":23.085296,"median":24.603297,"eighty":29.518959,"marketCap":406190534678},{"date":"2023-03-03","current":22.357292,"twenty":23.028549,"median":24.566079,"eighty":29.469644,"marketCap":401112176388},{"date":"2023-03-10","current":22.00746,"twenty":22.983363,"median":24.533047,"eighty":29.415426,"marketCap":394835846397},{"date":"2023-03-17","current":22.198308,"twenty":22.961748,"median":24.507475,"eighty":29.316327,"marketCap":398259841984},{"date":"2023-03-24","current":22.237641,"twenty":22.954123,"median":24.458598,"eighty":29.237465,"marketCap":398965513052},{"date":"2023-03-31","current":22.579982,"twenty":22.928011,"median":24.42796,"eighty":29.164815,"marketCap":405107464940},{"date":"2023-04-06","current":24.125619,"twenty":22.901879,"median":24.415005,"eighty":29.109707,"marketCap":432837724314},{"date":"2023-04-14","current":24.198457,"twenty":22.90067,"median":24.40122,"eighty":29.036089,"marketCap":434144522588},{"date":"2023-04-21","current":33.60045,"twenty":22.90067,"median":24.399299,"eighty":29.021363,"marketCap":427532123321},{"date":"2023-04-28","current":33.481314,"twenty":22.90067,"median":24.399299,"eighty":29.021363,"marketCap":426016237324},{"date":"2023-05-05","current":33.113231,"twenty":22.90067,"median":24.399299,"eighty":29.021363,"marketCap":421332755579},{"date":"2023-05-12","current":35.39488,"twenty":22.899462,"median":24.396569,"eighty":29.008716,"marketCap":450364456873},{"date":"2023-05-16","current":35.078285,"twenty":22.899462,"median":24.396569,"eighty":29.008716,"marketCap":446336102206},{"date":"2023-05-25","current":34.442897,"twenty":22.896558,"median":24.388256,"eighty":28.974086,"marketCap":438251418186},{"date":"2023-06-02","current":33.976799,"twenty":22.896316,"median":24.385274,"eighty":28.964288,"marketCap":432320784926},{"date":"2023-06-09","current":35.234384,"twenty":22.896073,"median":24.383122,"eighty":28.950456,"marketCap":448322304854},{"date":"2023-06-15","current":35.520199,"twenty":22.89583,"median":24.380969,"eighty":28.928156,"marketCap":451959013929},{"date":"2023-06-23","current":36.412821,"twenty":22.894676,"median":24.377907,"eighty":28.919594,"marketCap":463316736116},{"date":"2023-06-30","current":36.078638,"twenty":22.893522,"median":24.372178,"eighty":28.915612,"marketCap":459064583967},{"date":"2023-07-06","current":33.252114,"twenty":22.892945,"median":24.371306,"eighty":28.914218,"marketCap":423099894750},{"date":"2023-07-14","current":32.435159,"twenty":22.888195,"median":24.366246,"eighty":28.850983,"marketCap":412704958450},{"date":"2023-07-21","current":34.389724,"twenty":22.888195,"median":24.366246,"eighty":28.850983,"marketCap":437574843548},{"date":"2023-07-28","current":34.577457,"twenty":22.888195,"median":24.366246,"eighty":28.850983,"marketCap":451374121486},{"date":"2023-08-04","current":33.973355,"twenty":22.888195,"median":24.366246,"eighty":28.850983,"marketCap":443488171520},{"date":"2023-08-11","current":34.277968,"twenty":22.888195,"median":24.366246,"eighty":28.850983,"marketCap":447464594998},{"date":"2023-08-18","current":34.644301,"twenty":22.888195,"median":24.366246,"eighty":28.850983,"marketCap":452246699051},{"date":"2023-08-25","current":32.868384,"twenty":22.886611,"median":24.365921,"eighty":28.849875,"marketCap":429063890273},{"date":"2023-09-01","current":29.823849,"twenty":22.886611,"median":24.365921,"eighty":28.849875,"marketCap":389320523957},{"date":"2023-09-07","current":29.146873,"twenty":22.885028,"median":24.365597,"eighty":28.849755,"marketCap":380483275547},{"date":"2023-09-15","current":30.203841,"twenty":22.879503,"median":24.364936,"eighty":28.833726,"marketCap":394280941321},{"date":"2023-09-20","current":29.919769,"twenty":22.87674,"median":24.363504,"eighty":28.822576,"marketCap":390572668146},{"date":"2023-09-27","current":29.333179,"twenty":22.87009,"median":24.356583,"eighty":28.783898,"marketCap":382915324837},{"date":"2023-10-06","current":28.986391,"twenty":22.866716,"median":24.354651,"eighty":28.718771,"marketCap":378388342001},{"date":"2023-10-13","current":28.836976,"twenty":22.866716,"median":24.354651,"eighty":28.718771,"marketCap":376437886630},{"date":"2023-10-20","current":10.593286,"twenty":22.841783,"median":24.323515,"eighty":28.702887,"marketCap":366781928558},{"date":"2023-10-27","current":10.362392,"twenty":22.819032,"median":24.302934,"eighty":28.672744,"marketCap":358787469506},{"date":"2023-11-03","current":10.445631,"twenty":22.769044,"median":24.290222,"eighty":28.617079,"marketCap":361669539868},{"date":"2023-11-10","current":10.249567,"twenty":22.737382,"median":24.269161,"eighty":28.577268,"marketCap":354881014160},{"date":"2023-11-17","current":10.435898,"twenty":22.670731,"median":24.240678,"eighty":28.494304,"marketCap":361332520862},{"date":"2023-11-24","current":10.602761,"twenty":22.660327,"median":24.231704,"eighty":28.462978,"marketCap":367109989550},{"date":"2023-11-30","current":10.575646,"twenty":22.651742,"median":24.221347,"eighty":28.351474,"marketCap":366171150888},{"date":"2023-12-08","current":10.804387,"twenty":22.618791,"median":24.198457,"eighty":28.181371,"marketCap":374091097548},{"date":"2023-12-15","current":10.906591,"twenty":22.590739,"median":24.188733,"eighty":27.750808,"marketCap":377629797119},{"date":"2023-12-22","current":10.765452,"twenty":22.58102,"median":24.177986,"eighty":27.241581,"marketCap":372743021520},{"date":"2023-12-29","current":10.886428,"twenty":22.573561,"median":24.160465,"eighty":27.136313,"marketCap":376931686319},{"date":"2024-01-05","current":11.16801,"twenty":22.53203,"median":24.157661,"eighty":27.08647,"marketCap":386681164730},{"date":"2024-01-12","current":11.204163,"twenty":22.487074,"median":24.126144,"eighty":26.963348,"marketCap":387932949613},{"date":"2024-01-19","current":11.208335,"twenty":22.443298,"median":24.121091,"eighty":26.726065,"marketCap":388077386330},{"date":"2024-01-26","current":11.093616,"twenty":22.419215,"median":24.117255,"eighty":26.720851,"marketCap":384105376607},{"date":"2024-02-02","current":10.844498,"twenty":22.388887,"median":24.117255,"eighty":26.720851,"marketCap":381216642263},{"date":"2024-02-09","current":10.710277,"twenty":22.359324,"median":24.117255,"eighty":26.720851,"marketCap":376498376168},{"date":"2024-02-16","current":10.814367,"twenty":22.324374,"median":24.117255,"eighty":26.720851,"marketCap":380157439670},{"date":"2024-02-23","current":10.994416,"twenty":22.309859,"median":24.117255,"eighty":26.720851,"marketCap":386486701732},{"date":"2024-03-01","current":11.058142,"twenty":22.274272,"median":24.113418,"eighty":26.715636,"marketCap":388726855254},{"date":"2024-03-08","current":10.886151,"twenty":22.230938,"median":24.108604,"eighty":26.715636,"marketCap":382680849512},{"date":"2024-03-15","current":10.914049,"twenty":22.186179,"median":24.098462,"eighty":26.715636,"marketCap":383661560027},{"date":"2024-03-22","current":10.676861,"twenty":22.155506,"median":24.095837,"eighty":26.715636,"marketCap":375323710660},{"date":"2024-03-28","current":10.82836,"twenty":22.121795,"median":24.073645,"eighty":26.715636,"marketCap":380649331209},{"date":"2024-04-05","current":10.45407,"twenty":22.051165,"median":24.060772,"eighty":26.720851,"marketCap":367491915735},{"date":"2024-04-12","current":10.199745,"twenty":22.008009,"median":24.060772,"eighty":26.720851,"marketCap":358551620604},{"date":"2024-04-19","current":8.65562,"twenty":21.962919,"median":24.049911,"eighty":26.720851,"marketCap":351201782289},{"date":"2024-04-26","current":8.719762,"twenty":21.891108,"median":24.032177,"eighty":26.715636,"marketCap":353804347988},{"date":"2024-05-03","current":9.377517,"twenty":21.784557,"median":24.00846,"eighty":26.715636,"marketCap":360809343115},{"date":"2024-05-10","current":9.373138,"twenty":21.660958,"median":23.990791,"eighty":26.715636,"marketCap":360640875572},{"date":"2024-05-17","current":9.650236,"twenty":21.622619,"median":23.98343,"eighty":26.715636,"marketCap":371302464353},{"date":"2024-05-24","current":9.363756,"twenty":21.575231,"median":23.974857,"eighty":26.715636,"marketCap":360279873695},{"date":"2024-05-31","current":9.087284,"twenty":21.542202,"median":23.962574,"eighty":26.715636,"marketCap":349642351706},{"date":"2024-06-07","current":9.158591,"twenty":21.483343,"median":23.946685,"eighty":26.715636,"marketCap":352385965974},{"date":"2024-06-14","current":9.097918,"twenty":21.446612,"median":23.929686,"eighty":26.720851,"marketCap":350051487167},{"date":"2024-06-21","current":9.24366,"twenty":21.36611,"median":23.912184,"eighty":26.726065,"marketCap":355659049663},{"date":"2024-06-28","current":9.11981,"twenty":21.343437,"median":23.902291,"eighty":26.770681,"marketCap":350893824881},{"date":"2024-07-05","current":9.11293,"twenty":21.329201,"median":23.877595,"eighty":26.770681,"marketCap":350629090171},{"date":"2024-07-12","current":9.363756,"twenty":21.294957,"median":23.864994,"eighty":26.770681,"marketCap":360279873695},{"date":"2024-07-15","current":9.375015,"twenty":21.282675,"median":23.856229,"eighty":26.770681,"marketCap":360713075948},{"date":"2024-08-02","current":10.179086,"twenty":21.325495,"median":23.875766,"eighty":26.859196,"marketCap":386988491906},{"date":"2024-08-09","current":10.144894,"twenty":21.325495,"median":23.875766,"eighty":26.859196,"marketCap":385688580326},{"date":"2024-08-16","current":10.073344,"twenty":21.285584,"median":23.875766,"eighty":26.859196,"marketCap":382968394983},{"date":"2024-08-23","current":10.279762,"twenty":21.271585,"median":23.875766,"eighty":26.859196,"marketCap":390816009337},{"date":"2024-08-30","current":10.398801,"twenty":21.271585,"median":23.875766,"eighty":26.859196,"marketCap":395341627431},{"date":"2024-09-06","current":10.446923,"twenty":21.271585,"median":23.875766,"eighty":26.859196,"marketCap":397171132618},{"date":"2024-09-13","current":10.424762,"twenty":21.271585,"median":23.875766,"eighty":26.859196,"marketCap":396328597334},{"date":"2024-09-20","current":10.436159,"twenty":21.271585,"median":23.875766,"eighty":26.859196,"marketCap":396761901194},{"date":"2024-09-27","current":10.218977,"twenty":21.249331,"median":23.875766,"eighty":26.859196,"marketCap":388505055417},{"date":"2024-10-04","current":10.162623,"twenty":21.244537,"median":23.875766,"eighty":26.859196,"marketCap":386362608553},{"date":"2024-10-11","current":10.163256,"twenty":21.204151,"median":23.875766,"eighty":26.859196,"marketCap":386386680990},{"date":"2024-10-18","current":26.962637,"twenty":21.150041,"median":23.875766,"eighty":26.960825,"marketCap":395919365911},{"date":"2024-10-25","current":26.835716,"twenty":21.150041,"median":23.889093,"eighty":26.967068,"marketCap":394055651827},{"date":"2024-10-31","current":26.333991,"twenty":21.150041,"median":23.889093,"eighty":26.967068,"marketCap":386688325532},{"date":"2024-11-08","current":25.697817,"twenty":21.14935,"median":23.88615,"eighty":26.970043,"marketCap":377346748401},{"date":"2024-11-15","current":24.90096,"twenty":21.14935,"median":23.88615,"eighty":26.970043,"marketCap":365645700757},{"date":"2024-11-22","current":25.496144,"twenty":21.14935,"median":23.88615,"eighty":26.970043,"marketCap":374385372146},{"date":"2024-11-29","current":25.415802,"twenty":21.14935,"median":23.88615,"eighty":26.970043,"marketCap":373205636889},{"date":"2024-12-06","current":24.515649,"twenty":21.14935,"median":23.88615,"eighty":26.970043,"marketCap":359987786773},{"date":"2024-12-13","current":23.977852,"twenty":21.14935,"median":23.88615,"eighty":26.970043,"marketCap":352090783425},{"date":"2024-12-20","current":23.541712,"twenty":21.14935,"median":23.870477,"eighty":26.963219,"marketCap":345686506319},{"date":"2024-12-27","current":23.869637,"twenty":21.14935,"median":23.866899,"eighty":26.862222,"marketCap":350501752263},{"date":"2025-01-03","current":23.613856,"twenty":21.14935,"median":23.846327,"eighty":26.797423,"marketCap":346745860427},{"date":"2025-01-10","current":23.326922,"twenty":21.148658,"median":23.835219,"eighty":26.622639,"marketCap":342532520226},{"date":"2025-01-17","current":24.228715,"twenty":21.148658,"median":23.815222,"eighty":26.492194,"marketCap":355774446572},{"date":"2025-01-24","current":25.099803,"twenty":21.148658,"median":23.815222,"eighty":26.458097,"marketCap":353053832614},{"date":"2025-01-31","current":26.166168,"twenty":21.148658,"median":23.815222,"eighty":26.458097,"marketCap":368053323729},{"date":"2025-02-07","current":26.275715,"twenty":21.148658,"median":23.815222,"eighty":26.451023,"marketCap":369594202431},{"date":"2025-02-14","current":26.915876,"twenty":21.148658,"median":23.815222,"eighty":26.482684,"marketCap":378598712347},{"date":"2025-02-21","current":27.331738,"twenty":21.148658,"median":23.815222,"eighty":26.556741,"marketCap":384448233538},{"date":"2025-02-28","current":28.02496,"twenty":21.148658,"median":23.815222,"eighty":26.658356,"marketCap":394199081144},{"date":"2025-03-07","current":28.384408,"twenty":21.147967,"median":23.81824,"eighty":26.827657,"marketCap":399255076200},{"date":"2025-03-14","current":27.898297,"twenty":21.147967,"median":23.837873,"eighty":27.012809,"marketCap":392417444792},{"date":"2025-03-21","current":27.929289,"twenty":21.164087,"median":23.864994,"eighty":27.693395,"marketCap":392853376781},{"date":"2025-03-28","current":27.948135,"twenty":21.248131,"median":23.876669,"eighty":27.88488,"marketCap":393118460031},{"date":"2025-04-04","current":27.381051,"twenty":21.248131,"median":23.905254,"eighty":27.898419,"marketCap":385141864048},{"date":"2025-04-11","current":25.474211,"twenty":21.248531,"median":23.905255,"eighty":27.898389,"marketCap":358320258825},{"date":"2025-04-17","current":17.005945,"twenty":21.223208,"median":23.911283,"eighty":27.898389,"marketCap":370899663970},{"date":"2025-04-25","current":17.091836,"twenty":21.086751,"median":23.911734,"eighty":27.898419,"marketCap":372772933115},{"date":"2025-04-28","current":17.053224,"twenty":20.960139,"median":23.911734,"eighty":27.898419,"marketCap":371930807467}],"updateTime":1745981091975}}}